Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, Recursion announced positive Phase 1b/2 results for REC-4881, which is its ...
French AI startup Mistral today launched Devstral 2, a new generation of its AI model designed for coding, as the company seeks to catch up to bigger AI labs like Anthropic and other coding-focused ...
Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...
On Dec. 5, 2025, the confirmed and prospective 48 nations competing at the 2026 FIFA World Cup will learn their fates—and we now know the pots every country will be in when the group stage draw takes ...
The trend of AI researchers developing new, small open source generative models that outperform far larger, proprietary peers continued this week with yet another staggering advancement. The goal is ...
A week ago, Google disabled the ability to see 100 results per page by using a URL parameter in the Google Search URL bar. Since that change, rank-checking tools have become an absolute mess, and even ...
18 popular NPM packages with over 2 billion weekly downloads were compromised through a phishing attack targeting developer “Qix” The malware functioned as a “crypto-clipper,” silently replacing ...
SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $171.9 million in its second quarter. On a per-share basis, the Salt Lake City-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results